Business

OTC Markets Group Welcomes New OTCQB Companies – December 9

OTC Markets Group Welcomes New OTCQB Companies – December 9.

articleNika Pharmaceuticals Inc.December 9, 20245/company/nika-biotechnology-inc/news/otc-markets-group-welcomes-new-otcqb-companies-december-9
OTC Markets Group Welcomes New OTCQB Companies – December 9

About this update from Nika Pharmaceuticals Inc.

[{"type":"text","content":"OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, announced the following companies are approved for trading on the OTCQB Venture Market:  Devonian Health Group Inc. (TSX-V: GSD; OTCQB: DVHGF) is a late-stage botanical pharmaceutical corporation with novel therapeutic approaches to targeting unmet medical needs. F3 URANIUM CORP. (TSX-V: FUU; OTCQB: FUUFF) is a Canadian-based uranium project generator. Led by a world-class exploration team, the Company focuses on advancing the newly discovered JR Zone within the PLN property, located in the Western Athabasca Basin, Saskatchewan. LSEB CREATIVE CORP. (OTCQB: LSEB) is a specialty retailer that offers men and women elevated swimwear designs, constructed with the highest quality materials and techniques. With the recent substantial growth seen in the swimwear industry, our affluent, contemporary target market is in search of assortment and impressive concepts. NIKA PHARMACEUTICALS INC. (OTCQB: NIKA) is a pharmaceutical company, which specializes in the treatment of HIV/AIDS, Chronic Hepatitis B and C, Rheumatoid Arthritis, Cancer, Diabetes, and all diseases, for which a strengthened cell immunity is of vital importance.Saga Metals Corp. (TSX-V: SAGA; OTCQB: SAGMF) is a diversified critical mineral exploration company whose principal business is the acquisition and exploration of mineral assets that support the global green energy transition. The company currently has five 100 percent owned mineral properties focused on discovering uranium, lithium, titanium, vanadium and high-purity iron ore in Labrador and Quebec, Canada. Starpharma Holdings Ltd. (ASX: SPL; OTCQB: SPHRF) is an innovative biotechnology company with two decades of experience in advancing dendrimer technology from the lab to the patient. Our mission is to help patients with significant illnesses, such as cancer, achieve improved health outcomes and quality of life through the application of our unique dendrimer technology. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for these companies on www.otcmarkets.com. About OTC Markets Group Inc. OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven...

More updates from Nika Pharmaceuticals Inc.